Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2009 Nov 3:3:213-23.
doi: 10.2147/ppa.s4028.

Therapeutic options in the treatment of benign prostatic hyperplasia

Jaspreet S Sandhu  1
Affiliations

Therapeutic options in the treatment of benign prostatic hyperplasia

Jaspreet S Sandhu. Patient Prefer Adherence. .

Abstract

Current theraputic options for the treatment of symptomatic benign prostatic hyperplasia (BPH) are reviewed. Therapeutic options for mild lower urinary tract symptoms (LUTS), as defined by the American Urological Association, are generally treated medically. Moderate to severe LUTS can be treated medically or with surgical therapy. Current medical and surgical treatments for LUTS secondary to BPH are reviewed and evolving treatments are explored.

Keywords: TURP; benign prostatic hyperplasia; prostatectomy.

PubMed Disclaimer

References

    1. Berry SJ, Coffey DS, Walsh PC, et al. The development of human benign prostatic hyperplasia with age. J Urol. 1984;132:474–479. - PubMed
    1. Roehrborn CG, McConnell JD. Etiology, pathophysiology, epidemiology, and natural history of benign prostatic hyperplasia. In: Walsh PC, Retik AB, Vaughan ED, Wein AJ, editors. Campbell’s Urology. Philadelphia (PA): Saunders; 2002. pp. 1297–1336.
    1. McConnell MD, Bruskewitz R, Walsh P, et al. The effect of finasteride on the risk of acute urinary retention and the need for surgical treatment among men with benign prostatic hyperplasia. N Engl J Med. 1998;338:557–563. - PubMed
    1. McConnell JD, Roehrborn CG, Bautista AM, et al. The long-term effect of doxazosin, finasteride, and combination therapy on the clinical progression of benign prostatic hyperplasia. N Engl J Med. 2003;349:2385–2396. - PubMed
    1. McConnell JD. Prostatic growth: New insights into hormonal regulation. Br J Urol. 1995;76(Suppl 1):5–10. - PubMed

LinkOut - more resources